近十年来,心肌梗塞的抗凝治疗已渐被淘汰。Gross在1972年概括地综合了目前的观点:不论从临床及病理观察,有足够证据说明抗凝治疗并无价值。虽然亦有作者对心肌梗塞患者于住院期间采用抗凝治疗,但其出发点是为了减少血栓-栓塞现象,而不是认为它能减低病死率。然而,Modan最近报 In the past decade, anticoagulant therapy for myocardial infarction has gradually been eliminated. Gross summarized the current view in 1972 in general terms: There is good evidence from both clinical and pathological evidence that anticoagulant therapy is of no value. Although there are some authors who use anticoagulation during hospitalization for myocardial infarction, the starting point is to reduce thrombo-embolism instead of reducing mortality. However, Modan recently reported